Obsessive-compulsive Disorder

Overview

Journal BMJ

Specialty General Medicine

Date 2006 Aug 26

PMID 16931840

Citations 38

Authors

I Heyman

D Mataix-Cols

N A Fineberg

Affiliations

Soon will be listed here.

Citing Articles

Duration of Untreated Illness in Obsessive-Compulsive Disorder and its Associated Factors.

Auf A, Osman A Psychopharmacol Bull. 2024; 54(1):25-32.

PMID: 38449473 PMC: 10913869.

Opening new vistas on obsessive-compulsive disorder with the observing response task.

Pickenhan L, Milton A Cogn Affect Behav Neurosci. 2024; 24(2):249-265.

PMID: 38316708 PMC: 11039534. DOI: 10.3758/s13415-023-01153-w.

Obsessive-Compulsive Disorder (OCD): A Comprehensive Review of Diagnosis, Comorbidities, and Treatment Approaches.

Singh A, Anjankar V, Sapkale B Cureus. 2023; 15(11):e48960.

PMID: 38111433 PMC: 10726089. DOI: 10.7759/cureus.48960.

Investigating the effect of obsessive-compulsive disorder on clinical symptoms of temporomandibular joint disorders.

Sadrzadeh-Afshar M, Salari B, Shobeiri A, HafeziMotlagh K Clin Exp Dent Res. 2023; 9(6):1191-1199.

PMID: 37840225 PMC: 10728531. DOI: 10.1002/cre2.798.

App-Based Mindfulness Meditation Training and an Audiobook Intervention Reduce Symptom Severity but Do Not Modify Backward Inhibition in Adolescent Obsessive-Compulsive Disorder: Evidence from an EEG Study.

Rempel S, Backhausen L, McDonald M, Roessner V, Vetter N, Beste C J Clin Med. 2023; 12(7).

PMID: 37048570 PMC: 10095390. DOI: 10.3390/jcm12072486.

References

Heyman I, Fombonne E, Simmons H, Ford T, Meltzer H, Goodman R . Prevalence of obsessive-compulsive disorder in the British nationwide survey of child mental health. Br J Psychiatry. 2001; 179:324-9. DOI: 10.1192/bjp.179.4.324. View

Salkovskis P . Understanding and treating obsessive-compulsive disorder. Behav Res Ther. 1999; 37 Suppl 1:S29-52. View

Stein D . Obsessive-compulsive disorder. Lancet. 2002; 360(9330):397-405. DOI: 10.1016/S0140-6736(02)09620-4. View

Geller D, Biederman J, Stewart S, Mullin B, Martin A, Spencer T . Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder. Am J Psychiatry. 2003; 160(11):1919-28. DOI: 10.1176/appi.ajp.160.11.1919. View

Barrett P, Healy-Farrell L, March J . Cognitive-behavioral family treatment of childhood obsessive-compulsive disorder: a controlled trial. J Am Acad Child Adolesc Psychiatry. 2003; 43(1):46-62. DOI: 10.1097/00004583-200401000-00014. View

Swedo S, Leonard H, Rapoport J . The pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) subgroup: separating fact from fiction. Pediatrics. 2004; 113(4):907-11. DOI: 10.1542/peds.113.4.907. View

Saxena S, Brody A, Maidment K, Smith E, Zohrabi N, Katz E . Cerebral glucose metabolism in obsessive-compulsive hoarding. Am J Psychiatry. 2004; 161(6):1038-48. DOI: 10.1176/appi.ajp.161.6.1038. View

Mataix-Cols D, Wooderson S, Lawrence N, Brammer M, Speckens A, Phillips M . Distinct neural correlates of washing, checking, and hoarding symptom dimensions in obsessive-compulsive disorder. Arch Gen Psychiatry. 2004; 61(6):564-76. DOI: 10.1001/archpsyc.61.6.564. View

. Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial. JAMA. 2004; 292(16):1969-76. DOI: 10.1001/jama.292.16.1969. View

10.

Goodman W, Price L, Rasmussen S, Mazure C, Fleischmann R, Hill C . The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry. 1989; 46(11):1006-11. DOI: 10.1001/archpsyc.1989.01810110048007. View

11.

Pigott T, Lheureux F, Dubbert B, Bernstein S, Murphy D . Obsessive compulsive disorder: comorbid conditions. J Clin Psychiatry. 1994; 55 Suppl:15-27; discussion 28-32. View

12.

Mataix-Cols D, do Rosario-Campos M, Leckman J . A multidimensional model of obsessive-compulsive disorder. Am J Psychiatry. 2005; 162(2):228-38. DOI: 10.1176/appi.ajp.162.2.228. View

13.

Fineberg N, Gale T . Evidence-based pharmacotherapy of obsessive-compulsive disorder. Int J Neuropsychopharmacol. 2004; 8(1):107-29. DOI: 10.1017/S1461145704004675. View

14.

Wittchen H, Jacobi F . Size and burden of mental disorders in Europe--a critical review and appraisal of 27 studies. Eur Neuropsychopharmacol. 2005; 15(4):357-76. DOI: 10.1016/j.euroneuro.2005.04.012. View

15.

Layard R . The case for psychological treatment centres. BMJ. 2006; 332(7548):1030-2. PMC: 1450056. DOI: 10.1136/bmj.332.7548.1030. View

16.

Bloch M, Landeros-Weisenberger A, Kelmendi B, Coric V, Bracken M, Leckman J . A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Mol Psychiatry. 2006; 11(7):622-32. DOI: 10.1038/sj.mp.4001823. View

17.

Huppert J, Walther M, Hajcak G, Yadin E, Foa E, Simpson H . The OCI-R: validation of the subscales in a clinical sample. J Anxiety Disord. 2006; 21(3):394-406. DOI: 10.1016/j.janxdis.2006.05.006. View

18.

Zohar J, Judge R . Paroxetine versus clomipramine in the treatment of obsessive-compulsive disorder. OCD Paroxetine Study Investigators. Br J Psychiatry. 1996; 169(4):468-74. DOI: 10.1192/bjp.169.4.468. View

19.

Scahill L, Riddle M, Ort S, King R, Goodman W, Cicchetti D . Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity. J Am Acad Child Adolesc Psychiatry. 1997; 36(6):844-52. DOI: 10.1097/00004583-199706000-00023. View

20.

Skoog G, Skoog I . A 40-year follow-up of patients with obsessive-compulsive disorder [see commetns]. Arch Gen Psychiatry. 1999; 56(2):121-7. DOI: 10.1001/archpsyc.56.2.121. View